Comparison of cisplatin- and carboplatin-based third-generation chemotherapy in 1,014 Chinese patients with advanced non-small-cell lung cancer

Medical Oncology

Volumn 28, Issue 4, 2011, Pages 1418-1424

  Luo, Jie ^a   Leaw, Shiang J ^b   Xu, Ying ^a   Zheng, Di ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Advanced non small cell lung cancer; Carboplatin; Chemotherapy; Cisplatin; Overall survival

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; NAVELBINE; PACLITAXEL;

ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CHINESE; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; OVERALL SURVIVAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIAN CONTINENTAL ANCESTRY GROUP; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TAXOIDS; VINBLASTINE;

EID: 84655165044     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9575-3     Document Type: Article

References (25)

1. DM Parkin P Pisani J Ferlay 1993 Estimates of the worldwide incidence of eighteen major cancers in 1985 Int J Cancer 54 594 606
2. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin. 55 74 108
3. L Yang DM Parkin J Ferlay L Li Y Chen 2005 Estimates of cancer incidence in china for 2000 and projections for 2005 Cancer Epidermiol Biomarkers Prev 14 243 250
4. D Gu TN Kelly X Wu J Chen JM Samet JF Huang 2009 Mortality attributable to smoking in China N Engl J Med 360 150 159
5. CG Azzoli S Baker Jr S Temin W Pao T Aliff J Brahmer 2009 American society of clinical oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer J Clin Oncol 27 6251 6266
6. J Lokich N Anderson 1998 Carboplatin vs. cisplatin in solid tumors: an analysis of the literature Ann Oncol 9 13 21
7. T Berghmans M Paesmans JP Sculier 2001 Cisplatin or carboplatin for the treatment of non-small cell lung cancer: do they have equivalent efficacy? Lung Cancer 34 15 17
8. JC Soria T Le Chevalier 2002 Is cisplatin still the best platinum compound in non-small-cell lung cancer? Ann Oncol 13 1515 1517
9. LH Einhorn 2005 Carboplatin vs. cisplatin in lung cancer Lung Cancer 49 S32 S35
10. J Klastersky JP Sculier H Lacroix G Dabouis G Bureau P Libert 1990 A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small cell lung cancer: European organization for research and treatment of cancer protocol 07861 J Clin Oncol 8 1556 1562
11. S Jelić L Mitrović D Radosavljević E Elezar N Babović V Kovcin 2001 Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study Lung Cancer 34 1 13
12. D Bisset M Nicolson S Falk D Dunlop N Stares E Loh 2001 Randomized phase II study of tirapazamine with either cisplatin or carboplatin in advanced NSCLC Proc Am Soc Clin Oncol 20 346a
13. R Rosell U Gatzemeier DC Betticher U Keppler HN Macha R Pirker 2002 Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial Ann Oncol 13 1539 1549
14. JH Schiller D Harrington CP Belani C Langer A Sandler J Krook 2002 Eastern cooperative oncology group. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer N Engl J Med 346 92 98
15. P Zatloukal L Petruzelka M Zemanová V Kolek J Skricková M Pesek 2003 Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIB and IV non-small cell lung cancer (NSCLC): a phase III randomized trial Lung Cancer 41 321 331
16. F Fossella JR Pereira J von Pawel A Pluzanska V Gorbounova E Kaukel 2003 Randomized, multinational, phase III study of docetaxel plus platinum combinations vs. vinorelbine plus cisplatin for advanced non- small cell lung cancer: the TAX 326 Study Group J Clin Oncol 21 3016 3024
17. P Mazzanti C Massacesi MB Rocchi R Mattioli P Lippe R Trivisonne 2003 Randomized, multicenter, phase II study of gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer Lung Cancer 41 81 89
18. A Paccagnella A Favaretto F Oniga F Barbieri G Ceresoli W Torri 2004 GSTVP (Gruppo di Studio Tumori Polmonari del Veneto). Cisplatin vs. carboplatin in combination with mitomycin and vinblastine in advanced non-small cell lung cancer. A multicenter, randomized phase III trial Lung Cancer 43 83 91
19. K Kelly J Crowley PA Bunn Jr CA Presant PK Grevstad CM Moinpour 2001 Randomized phase III trial of paclitaxel plus carboplatin vs. vinorelbine plus cisplatin in the treatment of patients with advanced nonsmall-cell lung cancer: a Southwest Oncology Group trial J Clin Oncol 19 3210 3218
20. CG Azzoli MG Kris DG Pfister 2007 Cisplatin vs. carboplatin for patients with metastatic non-small-cell lung cancer-an old rivalry renewed J Natl Cancer Inst 99 828 829
21. A Ardizzoni L Boni M Tiseo FV Fossella JH Schiller M Paesmans 2007 CISCA (CISplatin vs. CArboplatin) Meta-analysis Group. Cisplatin- vs. carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis J Natl Cancer Inst 6 99 847 857
22. M McClellan JS Benner 2009 Four important steps toward 21st century care for patients with cancer The Oncologist 14 313 316
23. MJ Millward MJ Boyer M Lehnert S Clarke D Rischin BC Goh 2003 Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients Ann Oncol 14 449 454
24. W Schuette I Bork B Wollschläger S Schädlich 2001 Combination chemotherapy with docetaxel and carboplatin for advanced non-small cell lung cancer Clin Drug Inv 21 161 168
25. Treat J, Belani CP, Schiller J, Monberg MJ, Cunneen J, Chen R, Ye Z, et al. Gemcitabine (G) plus carboplatin (C) at AUC 5 demonstrates reduced grade 4 thrombocytopenia rate compared to AUC 5.5 in first line therapy of patients with advanced stage NSCLC. J Clin Oncol 2006; 24 (18 Suppl): 2006 ASCO Annual Meeting Proceedings Part I (abstr 7130).